Literature DB >> 19235575

Prognostic factors of recurrent respiratory papillomatosis from a registry of 72 patients.

Christine Martins Carvalho1, Laure Huot, Anne-Laure Charlois, Sonia Ayari Khalfallah, Francois Chapuis, Patrick Froehlich.   

Abstract

CONCLUSIONS: The database revealed severity factors relating to human papillomavirus (HPV) type and age at diagnosis. While not exhaustive, the database is easy to use and could serve for a European multicentre epidemiological study.
OBJECTIVES: To propose a database as a starting point for a national registry and to estimate prognostic factors in recurrent respiratory papillomatosis (RRP).
MATERIALS AND METHODS: This was a retrospective study carried out in a tertiary care teaching hospital. From January 2005 to July 2007, epidemiological, clinical and treatment information on patients undergoing endoscopy for RRP in the department was entered in a database. Data were collected on three forms: the first comprised information about disease history before assessment in the department, the second about the disease and its treatment in the department, and the third about evolution after treatment.
RESULTS: Data on 72 patients were entered into an RRP database between January 2005 and July 2007. In all, 82% had already been treated for RRP in a different centre; 24 had juvenile-onset (JORRP) and 48 adult-onset (AORRP) papillomatosis. Cidovir injections had been administered to 91% of the patients. Histology found nine cases of dysplasia, one of carcinoma in situ and one of invasive carcinoma. Subglottic and tracheal locations were significantly more frequent in JORRP than in AORRP, as were the maximum Derkay scores and annual numbers of endoscopies. Patients with type 11 HPV had significantly more endoscopies per year than those with type 6.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19235575     DOI: 10.1080/00016480902737986

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  4 in total

1.  The impact of cidofovir treatment on viral loads in adult recurrent respiratory papillomatosis.

Authors:  S Mikolajczak; G Quante; S Weissenborn; A Wafaisade; U Wieland; J C Lüers; J P Klussmann; D Beutner
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-07-06       Impact factor: 2.503

Review 2.  Recurrent respiratory papillomatosis: a complex defect in immune responsiveness to human papillomavirus-6 and -11.

Authors:  Vincent R Bonagura; Lynda J Hatam; David W Rosenthal; James A de Voti; Fung Lam; Bettie M Steinberg; Allan L Abramson
Journal:  APMIS       Date:  2010-06       Impact factor: 3.205

Review 3.  Recurrent respiratory papillomatosis: an overview.

Authors:  Qingliang Xue; Haitao Wang; Jianxin Wang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-05-28       Impact factor: 3.267

Review 4.  Juvenile-Onset Recurrent Respiratory Papillomatosis Diagnosis and Management - A Developing Country Review.

Authors:  R Y Seedat
Journal:  Pediatric Health Med Ther       Date:  2020-02-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.